Ohio State University Comprehensive Cancer Center — Columbus, Ohio

Public research footprint of Ohio State University Comprehensive Cancer Center, compiled from the ClinicalTrials.gov public registry.

1,208

Registered studies

607

Active

270

Recruiting now

438

Completed

128

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia Arising From Previous… · Metastatic Non-Cutaneous Melanoma · Myelodysplastic Syndrome · Recurrent Non-Cutaneous Melanoma

Recently updated registry entries

NCT02196181 — Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer… (Active Not Recruiting)
NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Ohio State University Comprehensive Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.